Harbour Investment Management LLC Has $5.48 Million Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Harbour Investment Management LLC lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 41,479 shares of the financial services provider’s stock after selling 625 shares during the period. iShares Biotechnology ETF comprises 2.4% of Harbour Investment Management LLC’s holdings, making the stock its 9th largest position. Harbour Investment Management LLC’s holdings in iShares Biotechnology ETF were worth $5,484,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $29,000. HHM Wealth Advisors LLC raised its holdings in shares of iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares in the last quarter. Bradley & Co. Private Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $32,000. Newbridge Financial Services Group Inc. bought a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $33,000. Finally, Hager Investment Management Services LLC bought a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.8 %

Shares of iShares Biotechnology ETF stock opened at $134.19 on Friday. The company has a market cap of $6.34 billion, a PE ratio of 24.52 and a beta of 0.84. The business has a 50 day moving average of $136.25 and a 200 day moving average of $139.96. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.